Poster Session
In conjunction with our inaugural scientific meeting, we are pleased to announce a virtual special poster session to highlight recent research and discoveries relevant to Glut1 Deficiency. We are excited about the opportunity to expand and share knowledge and promote scientific collaboration among those interested in and dedicated to helping patients and their families.
We invite participation from researchers, students, clinicians, dietitians, therapists, other healthcare professionals and patients/family members. Original posters as well as those presented recently at other meetings are welcomed, just please note any previous presentations in the application.
Posters of particular interest in light of the scientific meeting topics may be selected to participate in the Lightening Round presentations during the main conference sessions. All posters accepted will be available for viewing throughout the entire conference and will be included in our conference resources for later viewing.
We invite participation from researchers, students, clinicians, dietitians, therapists, other healthcare professionals and patients/family members. Original posters as well as those presented recently at other meetings are welcomed, just please note any previous presentations in the application.
Posters of particular interest in light of the scientific meeting topics may be selected to participate in the Lightening Round presentations during the main conference sessions. All posters accepted will be available for viewing throughout the entire conference and will be included in our conference resources for later viewing.
Abstract Information:
- Poster abstracts may be submitted through May 15, 2021.
- Decisions and notifications will be made within 5 days of submission.
- Please find the application submission here.
Subject Area Suggestions:
- Glut1 Deficiency symptoms
- quality of life impacts
- therapeutic diets (ketogenic, modified Atkins, others)
- therapies and interventions (physical, speech, occupational, behavior, other)
- clinical case studies
- individual patient/family experiences
- potential treatments (gene, RNA, enzyme, small molecule, other therapy)
- structure/function of glucose transporters
- blood brain barrier
- brain metabolism
- Glut1 cell biology
- role of Glut1 in astrocytes and endothelial cells
- Glut1 Deficiency animal models
- biomarkers
- glucose transporters in cancers
- Glut1 in other diseases
Additional Information:
- Please use the website form for submission.
- Limit the abstract title to 10 words or less.
- Limit the abstract body to 500 words or less, including acknowledgements.
- Provide 3-5 key words.
- Use standard abbreviations when possible. Nonstandard abbreviations/acronyms should be spelled out.
- List all contributing authors to the work. The presenting author should be listed first.
- The presenting author should be a registrant of the conference.
- Authors should disclose their sources of support (commercial, public or private grants).
- Work presented must conform to NIH policies on using animal and human subjects in neuroscience research, ethics policies, and where applicable to the Declaration of Helsinki.
- Work submitted for presentation shouldn't have been previously published in an archival scientific publication. However, recently presented posters are acceptable provided the other meetings and dates are included in the application.
- The scientific abstract should state the study's objective, briefly describe methods used, summarize the results obtained, and state the conclusions.
- The clinical case study abstract should include learning objectives and a brief summary of the patient presentation, workup, treatment, and main teaching points the case illustrates.
- The patient/family abstract could follow the clinical case study format above or contain unique presentation details to enhance understanding of the patient experience (examples: A Day in My Life, My Biggest Challenges, My Greatest Accomplishments, My Hope for the Future, Glut1 Deficiency's Impact on Our Family, etc.)
- Abstracts should be submitted in English.
- Authors will be notified of acceptance or rejection within 5 days of submission along with further instructions on submitting materials.
- Applications may be submitted through May 15, 2021.
Poster Presentation Details:
- We will utilize a virtual format for poster presentations.
- All authors accepted will be asked to pre-record a 3 to 5 minute video overview of their poster, including highlights and key takeaways.
- Posters will be submitted in PDF format.
- Each poster will be displayed with the following information:
|
- Poster presentations selected for the Lightning Round will have the pre-recorded video shared during the main conference session and the author will participate in a live Q&A.
Thank you sincerely for your interest in participating in the poster session and your willingness to add your knowledge and expertise to the greater community.
If you have questions about the poster session or the conference, please contact Glenna Steele, Executive Director of the Glut1 Deficiency Foundation.
If you have questions about the poster session or the conference, please contact Glenna Steele, Executive Director of the Glut1 Deficiency Foundation.
